Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 16, 2013

Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: should maternal age have a role in decision making?

  • Salvatore Gizzo EMAIL logo , Marco Noventa , Omar Anis , Carlo Saccardi , Alessandra Zambon , Stefania Di Gangi , Daniela Tormene , Michele Gangemi , Donato D’Antona and Giovanni Battista Nardelli

Abstract

In obstetrical practice, the best prevention strategy for pregnant women aged >35 years without known thrombosis risk factors who underwent elective caesarean delivery (CD) is controversial. We performed an observational-longitudinal cohort study on pregnant women aged >35 years who delivered at term by elective caesarean section after a physiological single pregnancy to evaluate the role of maternal age in the decision-making process of whether or not to perform low-molecular-weight heparin (LMWH) prophylaxis during the post-partum period after elective CD in healthy women with unknown inherited thrombophilia status. During the 6 post-partum weeks, we followed two groups: GROUP-A (349 women treated for 7 days with low-molecular-weight heparin) and GROUP-B (180 women not treated with LMWH treatment). The outcomes were as follows: onset of thromboembolic events during the post-partum period; non-obstetrical-linked maternal haemorrhage; blood transfusion; re-laparotomy; detection of a surgical site haematoma; length of hospitalisation; and treatment suspension because of decreased platelet count. Except for the parity number, the two groups were homogeneous with regard to general features. In both the groups, we reported no cases of thromboembolic events during the follow-up period. Maternal haemorrhage requiring transfusion occurred in 16 women in GROUP-A and none in GROUP-B. Among the GROUP-A women, 11 demonstrated a surgical site haematoma and 4 required re-laparotomy. No cases of treatment suspension were reported. Pneumatic compression stockings represent a better, low cost and safe way to prevent post-partum venous thromboembolic episodes after elective caesarean section in an unscreened population. Pharmacological prophylaxis after elective caesarean section should be performed only in case of clear and known adjunctive risk factors, independent of maternal age.


Corresponding author: Salvatore Gizzo, MD, Dipartimento di Salute della Donna e del Bambino, U.O.C. di Ginecologia e Ostetricia Via Giustiniani 3 35128 Padova, Italy, Tel.: +39 333 5727248, Fax: +39 049 8211785, E-mail:

References

[1] American College of Obstetricians and Gynecologists. Thromboembolism in pregnancy: clinical management guidelines for obstetricians and gynaecologists. American College of Obstetricians and Gynaecologists. Washington, DC: The College; 2000: Bullettin no. 19.Search in Google Scholar

[2] American College of Obstetricians and Gynecologists. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108:1039–47.Search in Google Scholar

[3] Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141: e691S–736S.10.1378/chest.11-2300Search in Google Scholar

[4] Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:844S–86S.10.1378/chest.08-0761Search in Google Scholar

[5] Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost. 2007;98:1237–45.10.1160/TH07-05-0329Search in Google Scholar

[6] Blondon M. Thromboprophylaxis after cesarean section: decision analysis. Thromb Res. 2011;127:S9–S12.10.1016/S0049-3848(11)70004-4Search in Google Scholar

[7] Blondon M, Perrier A, Nendaz M, Righini M, Boehlen F, Boulvain M, et al. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery. Thromb Haemost. 2010;103:129–37.10.1160/TH09-06-0349Search in Google Scholar PubMed

[8] Cavazza S, Rainaldi MP, Adduci A, Palareti G. Thromboprophylaxis following cesarean delivery: one site prospective pilot study to evaluate the application of a risk score model. Thromb Res. 2012;129:28–31.10.1016/j.thromres.2011.06.028Search in Google Scholar PubMed

[9] Chunilal SD, Bates SM. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb Haemost. 2009;101:428–38.10.1160/TH08-08-0526Search in Google Scholar

[10] Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J, et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol. 2007;197:457.e1–21.10.1016/j.ajog.2007.04.022Search in Google Scholar PubMed

[11] Favilli A, Acanfora MM, Bini V, Radicchi R, Di Renzo GC, Gerli S. Single indication of labor induction with prostaglandins: is advanced maternal age a risk factor for cesarean section? A matched retrospective cohort study. J Matern Fetal Neonatal Med. 2013;26: 665–8.10.3109/14767058.2012.746658Search in Google Scholar PubMed

[12] Gates S, Brocklehurst P, Ayers S, Bowler U. Thromboprophylaxis in Pregnancy Advisory Group. Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. Am J Obstet Gynecol. 2004;191:1296–303.10.1016/j.ajog.2004.03.039Search in Google Scholar PubMed

[13] Getahun D, Strickland D, Lawrence JM, Fassett MJ, Koebnick C, Jacobsen SJ. Racial and ethnic disparities in the trends in primary cesarean delivery based on indications. Am J Obstet Gynecol. 2009;201:22.e1–7.10.1016/j.ajog.2009.07.062Search in Google Scholar PubMed

[14] Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ 3rd.Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697–706.10.7326/0003-4819-143-10-200511150-00006Search in Google Scholar PubMed

[15] Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008;6:905–12.10.1111/j.1538-7836.2008.02961.xSearch in Google Scholar PubMed

[16] James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29:326–31.10.1161/ATVBAHA.109.184127Search in Google Scholar PubMed

[17] James A. Committee on Practice Bulletins – Obstetrics. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol. 2011;118:718–29.10.1097/AOG.0b013e3182310c4cSearch in Google Scholar PubMed

[18] James AH. Prevention and treatment of venous thromboembolism in pregnancy. Clin Obstet Gynecol. 2012;55:774–87.10.1097/GRF.0b013e31825cfe7bSearch in Google Scholar PubMed

[19] Larsen TB, Sørensen HT, Gislum M, Johnsen SP. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res. 2007;120:505–9.10.1016/j.thromres.2006.12.003Search in Google Scholar PubMed

[20] Lindqvist P, Dahlbäck B, Marsál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999;94:595–9.10.1097/00006250-199910000-00021Search in Google Scholar

[21] Lussana F, Dentali F, Abbate R, d’Aloja E, D’Angelo A, De Stefano V, et al. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2009;124:e19–25.10.1016/j.thromres.2009.06.031Search in Google Scholar PubMed

[22] Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913–30.10.1046/j.0007-1323.2001.01800.xSearch in Google Scholar PubMed

[23] Quiñones JN, James DN, Stamilio DM, Cleary KL, Macones GA. Thromboprophylaxis after cesarean delivery: a decision analysis. Obstet Gynecol. 2005;106:733–40.10.1097/01.AOG.0000178792.51401.3aSearch in Google Scholar PubMed

[24] Rodger MA, Avruch LI, Howley HE, Olivier A, Walker MC. Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after caesarean section. Am J Obstet Gynecol. 2006;194:436–7.10.1016/j.ajog.2005.07.044Search in Google Scholar PubMed

[25] Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top Guideline No. 52. May 2009.Search in Google Scholar

[26] Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. RCOG Green-top Guideline No. 37a. November 2009.Search in Google Scholar

[27] Sia WW, Powrie RO, Cooper AB, Larson L, Phipps M, Spencer P, et al. The incidence of deep vein thrombosis in women undergoing cesarean delivery. Thromb Res. 2009;123:550–5.10.1016/j.thromres.2008.06.004Search in Google Scholar PubMed

[28] Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56–60.Search in Google Scholar

[29] Snijder CA, Cornette JM, Hop WC, Kruip MJ, Duvekot JJ. Thrombophylaxis and bleeding complications after cesarean section. Acta Obstet Gynecol Scand. 2012;91:560–5.10.1111/j.1600-0412.2012.01351.xSearch in Google Scholar PubMed

[30] SOCG. Clinical Practice Guidelines. Prevention and Management of Postpartum Haemorrhage. No. 88, April 2000.Search in Google Scholar

[31] Vincent-Rohfritsch A, Le Ray C, Anselem O, Cabrol D, Goffinet F. Pregnancy in women aged 43 years or older: maternal and perinatal risks. J Gynecol Obstet Biol Reprod (Paris). 2012;41:468–75.10.1016/j.jgyn.2012.04.013Search in Google Scholar PubMed

[32] World Health Report. Determinants of caesarean section rates in developed countries: supply, demand and opportunities for control. 2010. No 29. (download available on http://www.who.int/healthsystems/topics/financing/healthreport/29DeterminantsC-section.pdf).Search in Google Scholar

[33] Zhang J, Troendle J, Reddy UM, Laughon SK, Branch DW, Burkman R, et al. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol. 2010;203:326.e1–10.10.1016/j.ajog.2010.06.058Search in Google Scholar PubMed PubMed Central

The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2013-7-2
Accepted: 2013-10-14
Published Online: 2013-11-16
Published in Print: 2014-5-1

©2014 by Walter de Gruyter Berlin Boston

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/jpm-2013-0160/html
Scroll to top button